Pharmaceutical composition containing at least one Compound 21 FGF (Fibroblast Growth Factor 21) and at least one receptor (glp-1r agonist of the glucagon like peptide 1 (P)； and its useTo prepare a Medicine for the treatment of at least one metabolic syndrome and / or Atherosclerosis in a patient.
RAO, ERCOLE,BOSCHEINEN, OLIVER,DREYER, MATTHIAS,HABERMANN, PAUL,SOMMERFELD, MARK,SCHAEFER, HANS LUDWING,SOMMERFELD MARK,BOSCHEINEN OLIVER,HABERMANN PAUL,RAO ERCOLE,DREYER MATTHIAS,SCHAEFER HANS LUDWING
申请号：
CL2012002031
公开号：
CL2012002031A1
申请日:
2012.07.20
申请国别(地区):
CL
年份:
2012
代理人:
摘要：
Pharmaceutical composition containing at least one Compound 21 FGF (Fibroblast Growth Factor 21) and at least one receptor (glp-1r agonist of the glucagon like peptide 1 (P)； and its useTo prepare a Medicine for the treatment of at least one metabolic syndrome and / or Atherosclerosis in a patient.<；p>；Composició；n farmacé；utica que contiene al menos un compuesto FGF-21 (factor de crecimiento de fibroblastos 21) y al menos un agonista del GLP-1R (receptor del pé；ptido 1 similar al glucagó；n)； y su uso para preparar un medicamento para el tratamiento de al menos un sí；ndrome metabó；lico y/o aterosclerosis en un paciente.<；/p>；
